loading

Applied Therapeutics Inc Azioni (APLT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 0.122 0.144 0.19
Operating Expenses
22.70%
25.52
33.02 29.86 20.58 21.28
Operating Income/Loss
22.70%
-25.52
-33.02 -29.74 -20.44 -21.09
Nonoperating Income/Loss
95.20%
3.70
77.03 -38.85 23.34 -62.84
Income/Loss From Continuing Operations Before Tax
149.59%
-21.82
44.01 0.122 2.898 -83.94
Income/Loss From Continuing Operations After Tax
149.59%
-21.82
44.01 -68.59 2.898 -83.94
Net Income/Loss
149.59%
-21.82
44.01 -68.59 2.898 -83.94
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8,720%
144.79
1.6415 144.35 143.93 125.32
Diluted Average Shares
8,720%
144.79
1.6415 144.35 152.39 125.32
Basic Earnings Per Share
145.45%
-0.15
0.33 -0.48 0.02 -0.67
Diluted Earnings Per Share
145.45%
-0.15
0.33 -0.48 -0.13 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):